Education
About Us
Working with TipRanks
Follow Us
Ajanta Pharma Limited (IN:AJANTPHARM)
:AJANTPHARM
Total Valuation
Ajanta Pharma Limited has a market cap or net worth of ₹329.22B. The enterprise value is ₹90.48B.
Market Cap₹329.22B
Enterprise Value₹90.48B
Share Statistics
Ajanta Pharma Limited has 124,912,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding124,912,100
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Ajanta Pharma Limited’s return on equity (ROE) is 0.24 and return on invested capital (ROIC) is 43.46%.
Return on Equity (ROE)0.24
Return on Assets (ROA)0.18
Return on Invested Capital (ROIC)43.46%
Return on Capital Employed (ROCE)0.56
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.93
Inventory Turnover1.18
Valuation Ratios
The current PE Ratio of Ajanta Pharma Limited is 35.60. Ajanta Pharma Limited’s PEG ratio is -1.35.
PE Ratio35.60
PS Ratio0.00
PB Ratio4.06
Price to Fair Value8.64
Price to FCF286.30
Price to Operating Cash Flow24.30
PEG Ratio-1.35
Income Statement
In the last 12 months, Ajanta Pharma Limited had revenue of 46.48B and earned 9.20B in profits. Earnings per share was 73.56.
Revenue46.48B
Gross Profit35.77B
Operating Income22.64B
Pretax Income11.89B
Net Income9.20B
EBITDA12.68B
Earnings Per Share (EPS)73.56
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Ajanta Pharma Limited pays an annual dividend of ₹28, resulting in a dividend yield of 2.05%
Dividend Per Share₹28
Dividend Yield2.05%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.26
52-Week Price Change10.31%
50-Day Moving Average2.60K
200-Day Moving Average2.84K
Relative Strength Index (RSI)53.34
Average Volume (3m)3.18K
Important Dates
Ajanta Pharma Limited upcoming earnings date is Jul 24, 2025, TBA Not Confirmed.
Last Earnings DateApr 30, 2025
Next Earnings DateJul 24, 2025
Ex-Dividend DateNov 06, 2024
Financial Position
Ajanta Pharma Limited as a current ratio of 2.85, with Debt / Equity ratio of 1.60%
Current Ratio2.85
Quick Ratio1.95
Debt to Market Cap0.00
Net Debt to EBITDA-0.10
Interest Coverage Ratio109.20
Taxes
In the past 12 months, Ajanta Pharma Limited has paid 2.69B in taxes.
Income Tax2.69B
Effective Tax Rate0.23
Enterprise Valuation
Ajanta Pharma Limited EV to EBITDA ratio is 25.73, with an EV/FCF ratio of 38.88.
EV to Sales7.02
EV to EBITDA25.73
EV to Free Cash Flow38.88
EV to Operating Cash Flow28.20
Balance Sheet
Ajanta Pharma Limited has ₹6.15B in cash and marketable securities with ₹474.20M in debt, giving a net cash position of -₹5.68B billion.
Cash & Marketable Securities₹6.15B
Total Debt₹474.20M
Net Cash-₹5.68B
Net Cash Per Share-₹45.43
Tangible Book Value Per Share₹299.09
Margins
Gross margin is 79.00%, with operating margin of 48.70%, and net profit margin of 19.80%.
Gross Margin79.00%
Operating Margin48.70%
Pretax Margin25.58%
Net Profit Margin19.80%
EBITDA Margin27.29%
EBIT Margin24.19%
Analyst Forecast
The average price target for Ajanta Pharma Limited is ₹3,140.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹3,140.00
Price Target Upside16.26% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―